(Q35073541)

6 August 2017

1 reference

title

Benzimidazole treatment of cystic echinococcosis (English)

1 reference

6 August 2017

0 references

Joseph El-On

1

1 reference

6 August 2017

publication date

1 February 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

85

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

243-252

1 reference

Assessment of the immunological surveillance value of humoral and lymphocyte assays in severe human cystic echinococcosis

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

ANTIPARASITIC DRUGS. IV. 2-(4'-THIAZOLYL)-BENZIMIDAZOLE, A NEW ANTHELMINTIC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Immunological follow-up of hydatid cyst cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Development of chemotherapeutic model for the in vitro screening of drugs against Echinoccus granulosus cysts: the effects of an albendazole-albendazole sulphoxide combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Detection of specific circulating antigen, immune complexes and antibodies in human hydatidosis from Turkana (Kenya) and Great Britain, by enzyme-immunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

A new therapeutic approach for the treatment of cystic echinococcosis: percutaneous albendazole sulphoxide injection without reaspiration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Antibody and Th1/Th2-type responses in BALB/c mice inoculated with live or dead Echinococcus granulosus protoscoleces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Modulation of the cellular immune response by a carbohydrate rich fraction from Echinococcus granulosus protoscoleces in infected or immunized Balb/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

A clinical-radiological evaluation of benzimidazoles in the management of Echinococcus granulosus cysts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Mebendazole in Enterobiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Interaction of anthelmintic benzimidazoles with Ascaris suum embryonic tubulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Radical surgical therapy of abdominal cystic hydatid disease: factors of recurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

The metabolism of benzimidazole anthelmintics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Chemotherapy of Echinococcus infection in man with albendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Benzimidazoles in a wormy world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Orbital hydatid cyst: treatment and prevention of recurrences with albendazole plus praziquantel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

A placebo controlled study of albendazole in the treatment of pulmonary echinococcosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Cellular and humoral immune responses of hydatidosis patients to Echinococcus granulosus purified antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Mode of action of benzimidazoles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Biochemistry of benzimidazole resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

A routine diagnostic assay for the detection of benzimidazole resistance in parasitic nematodes using tritiated benzimidazole carbamates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. An example of a complex study covering both tolerance and pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Pre-operative albendazole therapy for hydatid cyst

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Penetration of albendazole sulphoxide into hydatid cysts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Three- to 7-year follow-up after albendazole treatment of 68 patients with cystic echinococcosis (hydatid disease)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

PAIR as percutaneous treatment of hydatid liver cysts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Antibody avidity determination by ELISA using thiocyanate elution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

In vitro production of cytokines by peripheral blood mononuclear cells from hydatid patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Cytokine patterns in seropositive and seronegative patients with Echinococcus granulosus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Albendazole as a potential treatment for human hydatidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Combination chemotherapy is more effective in postspillage prophylaxis for hydatid disease than either albendazole or praziquantel alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Treatment of Echinococcus granulosus hydatid disease with mebendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Therapy of human hydatid disease with mebendazole and albendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

The efficacy of praziquantel against cestodes in animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Evaluation of response to chemotherapy of human cystic echinococcosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Chemotherapy of human cystic echinococcosis: comparative efficacy of mebendazole and albendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Echinococcus granulosus: praziquantel treatment against the metacestode stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

In vitro effect of praziquantel and albendazole combination therapy on the larval stage of Echinococcus granulosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

Effect of mebendazole on human cystic echinococcosis: the role of dosage and treatment duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

A clinical trial of mebendazole in the treatment of alveolar hydatid disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

The efficacy of chemotherapy with mebendazole in human cystic echinococcosis: long-term follow-up of 52 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Treatment of Echinococcus granulosus hydatid disease with albendazole

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Optimal timing of post-operative albendazole prophylaxis in E. granulosus

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2802%2900217-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0001-706X(02)00217-6

1 reference

6 August 2017

1 reference